INSM Q1 2026 Earnings EPS Beat of 2234 But Stock Declines 3 ACAD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds OXM Q1 2026 Earnings Major EPS Miss but Stock Surges 8 OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Portfolio Performance Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances CTO Q1 2026 Earnings Massive EPS Surprise of 374 as FFO Exceeds Expectations